Insider Transactions in Q4 2021 at Sage Therapeutics, Inc. (SAGE)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 23
2021
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+1.92%
|
$1,000
$1.36 P/Share
|
|
Nov 22
2021
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+4.75%
|
$2,500
$1.36 P/Share
|
|
Nov 09
2021
|
Steven M Paul |
BUY
Other acquisition or disposition
|
Indirect |
1
+50.0%
|
$43
$43.36 P/Share
|
|
Oct 19
2021
|
Stephen Kanes Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,120
-7.68%
|
$44,800
$40.29 P/Share
|
|
Oct 19
2021
|
Stephen Kanes Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,800
+20.66%
|
-
|
|
Oct 19
2021
|
Jeffrey M Jonas |
SELL
Payment of exercise price or tax liability
|
Direct |
4,374
-5.13%
|
$174,960
$40.29 P/Share
|
|
Oct 19
2021
|
Jeffrey M Jonas |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+10.5%
|
-
|
|
Oct 19
2021
|
Anne Marie Cook SVP, GC & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,116
-12.39%
|
$44,640
$40.29 P/Share
|
|
Oct 19
2021
|
Anne Marie Cook SVP, GC & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
3,800
+29.66%
|
-
|
|
Oct 19
2021
|
Albert Robichaud Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,116
-0.78%
|
$44,640
$40.29 P/Share
|
|
Oct 19
2021
|
Albert Robichaud Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,800
+2.58%
|
-
|
|
Oct 19
2021
|
Kimi Iguchi CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,024
-2.11%
|
$40,960
$40.29 P/Share
|
|
Oct 19
2021
|
Kimi Iguchi CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
3,800
+7.25%
|
-
|